Carlson Capital Management Has Upped Abbott Labs (ABT) Holding; Long Pond Capital LP Has Raised Its Macerich Co (Call) (MAC) Holding

Abbott Laboratories (NYSE:ABT) Logo

Long Pond Capital Lp increased Macerich Co (Call) (MAC) stake by 23.44% reported in 2017Q4 SEC filing. Long Pond Capital Lp acquired 417,808 shares as Macerich Co (Call) (MAC)’s stock declined 14.88%. The Long Pond Capital Lp holds 2.20M shares with $144.50 million value, up from 1.78 million last quarter. Macerich Co (Call) now has $8.85 billion valuation. The stock increased 4.33% or $2.43 during the last trading session, reaching $58.55. About 1.95M shares traded or 11.88% up from the average. Macerich Company (NYSE:MAC) has declined 12.03% since April 5, 2017 and is downtrending. It has underperformed by 23.58% the S&P500.

Carlson Capital Management increased Abbott Labs (ABT) stake by 927.12% reported in 2017Q4 SEC filing. Carlson Capital Management acquired 55,173 shares as Abbott Labs (ABT)’s stock rose 5.88%. The Carlson Capital Management holds 61,124 shares with $3.49 million value, up from 5,951 last quarter. Abbott Labs now has $103.84B valuation. The stock increased 0.78% or $0.46 during the last trading session, reaching $59.46. About 7.41M shares traded or 3.55% up from the average. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 5, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Among 23 analysts covering The Macerich Company (NYSE:MAC), 6 have Buy rating, 2 Sell and 15 Hold. Therefore 26% are positive. The Macerich Company has $102 highest and $55.0 lowest target. $71.15’s average target is 21.52% above currents $58.55 stock price. The Macerich Company had 64 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Neutral” rating by JP Morgan on Tuesday, March 27. The rating was upgraded by Evercore to “Hold” on Friday, January 26. As per Monday, February 12, the company rating was maintained by RBC Capital Markets. The firm has “Neutral” rating by Boenning & Scattergood given on Wednesday, April 6. As per Thursday, September 28, the company rating was maintained by KeyBanc Capital Markets. The rating was upgraded by Boenning & Scattergood on Wednesday, August 23 to “Buy”. Barclays Capital maintained the stock with “Equal-Weight” rating in Tuesday, January 30 report. The stock has “Outperform” rating by Wells Fargo on Tuesday, December 19. The stock of Macerich Company (NYSE:MAC) has “Neutral” rating given on Monday, August 14 by Citigroup. The rating was maintained by Deutsche Bank with “Hold” on Monday, March 21.

Investors sentiment increased to 1.09 in 2017 Q4. Its up 0.14, from 0.95 in 2017Q3. It increased, as 28 investors sold MAC shares while 106 reduced holdings. 56 funds opened positions while 90 raised stakes. 135.39 million shares or 0.30% more from 134.98 million shares in 2017Q3 were reported. Tci Wealth holds 59 shares. Amica Pension Fund Board Of Trustees holds 4,162 shares. Voya Investment Mngmt Ltd Liability holds 63,798 shares. Schroder Mngmt Group Inc has 0% invested in Macerich Company (NYSE:MAC) for 13,229 shares. Huntington Bank & Trust holds 447 shares or 0% of its portfolio. Cohen & Steers Inc has 262,287 shares. Barclays Public Ltd Com reported 0.05% in Macerich Company (NYSE:MAC). Eaton Vance Mngmt reported 5,261 shares. Cadence Cap Llc has 8,175 shares. 1.43 million were reported by Third Point Ltd. Qs Invsts Lc holds 11,197 shares or 0.01% of its portfolio. 4,340 were accumulated by Liberty Mutual Gp Asset Inc. Livforsakringsbolaget Skandia Omsesidigt invested in 1,804 shares or 0.01% of the stock. 39,834 were accumulated by American Intll Group. State Street invested in 0.04% or 6.84 million shares.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Qs Investors Ltd Llc invested in 85,041 shares. Parallax Volatility Advisers Lp owns 115,275 shares for 0.01% of their portfolio. Ironwood Ltd owns 0.01% invested in Abbott Laboratories (NYSE:ABT) for 230 shares. Loeb Prtnrs Corporation reported 0.31% stake. Adirondack Trust Co holds 0.3% in Abbott Laboratories (NYSE:ABT) or 7,294 shares. Gulf Intll State Bank (Uk) Ltd accumulated 550,350 shares. Jones Fin Lllp holds 0.02% or 156,951 shares. Massachusetts-based Birch Hill Invest Advsrs has invested 0.09% in Abbott Laboratories (NYSE:ABT). Miracle Mile Advsr Ltd Liability Co has 0.05% invested in Abbott Laboratories (NYSE:ABT) for 5,400 shares. Rmsincerbeaux Mngmt Limited Liability reported 26,850 shares. Rhumbline Advisers invested in 0.36% or 3.15 million shares. Bryn Mawr Trust invested in 439,420 shares or 1.37% of the stock. Vaughan David Investments Il holds 1.3% in Abbott Laboratories (NYSE:ABT) or 489,548 shares. Private Asset Mgmt invested in 0.07% or 8,028 shares. Osborne Prns Cap reported 182,587 shares stake.

Since October 23, 2017, it had 1 buy, and 19 insider sales for $28.95 million activity. Contreras Jaime sold 6,284 shares worth $375,381. Fussell Stephen R sold $667,804 worth of stock or 11,106 shares. Bracken Sharon J sold 2,100 shares worth $126,559. Shares for $1.56 million were sold by Salvadori Daniel Gesua Sive. 42,665 shares valued at $2.69M were sold by Ford Robert B on Tuesday, January 30. Watkin Jared also sold $17,609 worth of Abbott Laboratories (NYSE:ABT) shares. Another trade for 1,220 shares valued at $71,970 was sold by Funck Robert E.

Macerich Company (NYSE:MAC) Institutional Positions Chart